Utility of Serum and Urinary Transforming Growth Factor-Beta Levels as Markers of Diabetic Nephropathy

Publisher： Karger

E-ISSN： 2235-3186|86|2|234-235

ISSN： 1660-8151

Source： Nephron, Vol.86, Iss.2, 2000-09, pp. : 234-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Increased Excretion of Urinary Transforming Growth Factor Beta 1 in Patients with Diabetic Nephropathy

By  

American Journal of Nephrology, Vol. 18, Iss. 6, 1998-12 ,pp. : 490-494

Karger

Access to resources Recommend Favorite

Novel Aspects of Transforming Growth Factor-Beta in Diabetic Kidney Disease

By  

Nephron, Vol. 92, Iss. 1, 2002-08 ,pp. : 7-21

Karger

Access to resources Recommend Favorite

Failure of Urinary and Serum Hepatocyte Growth Factor Assay as an Early Marker of Diabetic Nephropathy

By  

Nephron, Vol. 82, Iss. 4, 1999-08 ,pp. : 365-365

Karger

Access to resources Recommend Favorite

Heparin Treatment Reduces Glomerular Injury in Rats with Adriamycin-Induced Nephropathy but Does Not Modify Tubulointerstitial Damage or the Renal Production of Transforming Growth Factor-Beta

By  

Nephron, Vol. 84, Iss. 3, 2000-03 ,pp. : 248-257

Karger

Access to resources Recommend Favorite

Persistent Transforming Growth Factor-Beta 1 Expression May Predict Peritoneal Fibrosis in CAPD Patients with Frequent Peritonitis Occurrence

By  

American Journal of Nephrology, Vol. 18, Iss. 6, 1998-12 ,pp. : 513-519

Karger

Access to resources Recommend Favorite